Houston, TX, United States of America

Charles A Conrad

USPTO Granted Patents = 22 

 

 

Average Co-Inventor Count = 3.7

ph-index = 8

Forward Citations = 207(Granted Patents)


Location History:

  • Newport Beach, CA (US) (1999)
  • Houston, TX (US) (2000 - 2019)
  • (2019)
  • Spring, TX (US) (2002 - 2021)
  • Austin, TX (US) (2021 - 2024)

Company Filing History:


Years Active: 1999-2024

Loading Chart...
Loading Chart...
Loading Chart...
22 patents (USPTO):Explore Patents

Title: Charles A. Conrad: Innovator in Cancer Therapeutics and Glycolysis Inhibition

Introduction

Charles A. Conrad, based in Houston, Texas, is a distinguished inventor with an impressive portfolio comprising 22 patents. His innovative contributions primarily focus on the fields of cancer treatment and biochemical methods of inhibition, reflecting his dedication to advancing medical science.

Latest Patents

Among his latest patents are groundbreaking developments such as "Esters of 2-deoxy-monosaccharides with anti-proliferative activity." This patent discloses compounds and methods aimed at inhibiting glycolysis, thereby providing potential treatments for cancer and various other diseases. Another notable patent is related to "Adenovirus and immunomodulator combination therapy," which explores enhancements in the effectiveness of adenoviral cancer therapies, showcasing his commitment to improving therapeutic outcomes in oncology.

Career Highlights

Charles has made significant strides in his career, particularly during his tenure with the University of Texas System. His work demonstrates a persistent drive to harness scientific research for practical applications, particularly in the realms of health and medicine. His 22 patents bear testimony to his innovative approach and unwavering dedication to finding solutions to complex medical challenges.

Collaborations

Throughout his career, Charles has collaborated with remarkable individuals, including Timothy Madden and Waldemar Priebe. These partnerships have likely enriched his research pursuits and contributed to the success of his innovative endeavors in the medical field.

Conclusion

Charles A. Conrad stands out as a remarkable inventor whose efforts in patenting significant medical advancements are crucial to enhancing cancer therapies and the understanding of glycolytic pathways. His dedication to innovation continues to inspire future generations of inventors and researchers in the field of medicine.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…